MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the share capital was ...
Management reaffirmed 2026 adjusted guidance of total revenues of EUR 2 billion to EUR 2.3 billion, adjusted R&D expenses of EUR 2.2 billion to EUR 2.5 billion, and adjusted SG&A expenses of EUR 700 ...
MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results